scholarly journals The Lack of the C-Terminal Domain of Adipose Triglyceride Lipase Causes Neutral Lipid Storage Disease through Impaired Interactions with Lipid Droplets

2008 ◽  
Vol 93 (7) ◽  
pp. 2877-2884 ◽  
Author(s):  
Kunihisa Kobayashi ◽  
Toyoshi Inoguchi ◽  
Yasutaka Maeda ◽  
Naoki Nakashima ◽  
Asako Kuwano ◽  
...  
2007 ◽  
Vol 36 (6) ◽  
pp. 856-859 ◽  
Author(s):  
Masashi Akiyama ◽  
Kaori Sakai ◽  
Masaya Ogawa ◽  
James R. McMillan ◽  
Daisuke Sawamura ◽  
...  

2006 ◽  
Vol 39 (1) ◽  
pp. 28-30 ◽  
Author(s):  
Judith Fischer ◽  
Caroline Lefèvre ◽  
Eva Morava ◽  
Jean-Marie Mussini ◽  
Pascal Laforêt ◽  
...  

2008 ◽  
Vol 377 (3) ◽  
pp. 843-846 ◽  
Author(s):  
Filomena Campagna ◽  
Luisa Nanni ◽  
Fabiana Quagliarini ◽  
Elena Pennisi ◽  
Constantine Michailidis ◽  
...  

2009 ◽  
Vol 297 (2) ◽  
pp. E289-E296 ◽  
Author(s):  
Martina Schweiger ◽  
Achim Lass ◽  
Robert Zimmermann ◽  
Thomas O. Eichmann ◽  
Rudolf Zechner

Neutral lipid storage disease (NLSD) is a group of autosomal recessive disorders characterized by the excessive accumulation of neutral lipids in multiple tissues. Recently, two genes, adipose triglyceride lipase ( ATGL/ PNPLA2) and comparative gene identification-58 ( CGI-58/ABHD5), have been shown to cause NLSD. ATGL specifically hydrolyzes the first fatty acid from triacylglycerols (TG) and CGI-58/ABHD5 stimulates ATGL activity by a currently unknown mechanism. Mutations in both the ATGL and the CGI-58 genes are associated with systemic TG accumulation, yet the resulting clinical manifestations are not identical. Patients with defective ATGL function suffer from more severe myopathy (NLSDM) than patients with defective CGI-58 function. On the other hand, CGI-58 mutations are always associated with ichthyosis (NLSDI), which was not observed in patients with defective ATGL function. These observations indicate an ATGL-independent function of CGI-58. This review summarizes recent findings with the goal of relating structural variants of ATGL and CGI-58 to functional consequences in lipid metabolism.


2018 ◽  
Vol 28 (7) ◽  
pp. 606-609 ◽  
Author(s):  
Caitlin S. Latimer ◽  
Jennifer Schleit ◽  
Adam Reynolds ◽  
Desiree A. Marshall ◽  
Benjamin Podemski ◽  
...  

2020 ◽  
Vol 83 (3) ◽  
pp. 317-322
Author(s):  
Makoto Samukawa ◽  
Naoko Nakamura ◽  
Makito Hirano ◽  
Miyuki Morikawa ◽  
Hanami Sakata ◽  
...  

Mutations in the PNPLA2 gene cause neutral lipid storage disease with myopathy (NLSDM) or triglyceride deposit cardiomyovasculopathy. We report a detailed case study of a 53-year-old man with NLSDM. The PNPLA2 gene was analyzed according to the reported method. We summarized the clinical, laboratory, and genetic information of 56 patients, including our patient and 55 other reported patients with homozygous or compound heterozygous mutations in the PNPLA2 gene. We found a novel homozygous mutation (c.194delC) in the PNPLA2 gene that resulted in frameshift. The patient suffered from normal-tension glaucoma and pulmonary cysts, symptoms that are relatively common in the elderly but were not previously reported for this disease. Our summary confirmed that Jordan’s anomaly, polymorphonuclear leukocytes with lipid accumulation, was the most consistent finding of this disease. Because this disease is potentially treatable, our results may help rapid and correct diagnosis.


Sign in / Sign up

Export Citation Format

Share Document